Fibroblasts in asthma pathogenesis Sample Clauses

Fibroblasts in asthma pathogenesis. The remodelling in the airways as seen in asthma is largely a result of altered fibroblast behaviour (Spoelstra, Xxxxxx, & Xxxxxxxx 2001). Of particular interest in connection with asthma are myofibroblasts, which are contractile, smooth muscle-like fibroblasts often classified on the basis of the filaments they contain, ie. desmin and alpha-smooth muscle actin (α-SMA) (Xxxxxx et al. 1999). An increased number of myofibroblasts beneath the reticular basement membrane has been reported in airways of patients with chronic asthma (Xxxxx, Xxxxxx, & Xxxxxxx 2009). Xxxxxxxx et al found that the numbers of fibroblasts in the bronchial mucosal subepithelial compartment were increased in severe asthmatics compared with mild asthmatics and controls, leading to the conclusion that fibroblast accumulation is a selective determinant of severe persistent asthma (Xxxxxxxx et al. 2003). Activated fibroblasts or myofibroblasts may also be involved in the deposition of extracellular matrix and formation of airway fibrosis in asthma (Cai et al. 2008). Fibrocytes are progenitor cells in peripheral blood, which may migrate into the tissue and differentiate into fibroblast-like cells. In mild asthmatics an increased number of fibrocytes in tissue have been correlated with a thicker basement membrane (Xxxxxxxx et al. 2006). In response to activation by the pro- inflammatory cytokines IL-1β and TNF-α, fibroblasts synthesise and secrete a wide range of inflammatory mediators, including IL-6, IL-8, TGF-β, and FGFs (Xxxxxxx-Xxxxxx et al. 1996).
AutoNDA by SimpleDocs

Related to Fibroblasts in asthma pathogenesis

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • GARBAGE DISPOSAL, RECYCLING, AND BIODEGRADABLE MATERIALS A. Concessionaire shall be responsible for maintaining the cleanliness of the Concession Premises. Concessionaire shall ensure placement of all garbage and trash generated by the Concession Operation in designated containers and that said containers are emptied daily, or as more frequently required by Department, at a location within the Area designated by Department. Disposal costs from this latter location shall be borne by Department. Concessionaire shall provide such additional trash containers as may be required to keep the immediate Concession Premises clean at all times. The type of trash containers provided by Concessionaire shall be approved by Department prior to use.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

Time is Money Join Law Insider Premium to draft better contracts faster.